Pharmacogenomics-Supported Psychotropic Prescribing Trial
Recruiting · NCT06929533 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Manitoba
View the official record on ClinicalTrials.gov →Interventions studied
Pharmacogenetic Testing
What this trial is about
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aged 18 years or older
- The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
- The treating clinician thinks PGx testing can benefit and refers the patient to the study
Exclusion criteria
- Unwillingness to donate saliva samples for genetic analysis
- History of liver or bone marrow (hematopoietic cell) transplantation
- PGx testing results are already available
- No personal health identification number (PHIN) is available
Where it is running
6 locations listed.
- Shared Health Facilities - Winnipeg, Manitoba, Canada
- University of Manitoba College of Pharmacy - Winnipeg, Manitoba, Canada
- Shared Health Facilities - Winnipeg, Manitoba, Canada
- University of Manitoba College of Pharmacy - Winnipeg, Manitoba, Canada
- Shared Health Facilities - Winnipeg, Manitoba, Canada
- University of Manitoba College of Pharmacy - Winnipeg, Manitoba, Canada